| 中文名 | 2-(3-(顺式-3-甲基-1-(4-甲基-4H-1,2,4-三唑-3-基)环丁基)苯基)-6-(((S)-3-甲基哌啶-1-基)甲基)-4-(三氟甲基)异吲哚啉-1-酮 |
|---|---|
| 英文名 | Cbl-b-IN-3 |
| 英文别名 |
2-(3-(cis-3-Methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl)phenyl)-6-(((S)-3-methylpiperidin-1-yl)methyl)-4-(trifluoromethyl)isoindolin-1-one
Cbl-b inhibitor NX-1607 (Compound 23) 1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl) 2-(3-((1s,3R)-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl)phenyl)-6-(((S)-3-methylpiperidin-1-yl)methyl)-4-(trifluoromethyl)isoindolin-1-one 6-{[(3S)-3-methylpiperidin-1-yl]methyl}-2-{3-[(1r,3s)-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl}-4-(trifluoromethyl)-2,3-dihydro-1H-isoindol-1-one |
| 描述 | Cbl-b-IN-3(化合物23)是一种casitas b系淋巴瘤原癌基因-b(Cbl-b)抑制剂,IC50<1nM。Cbl-b是一种负调节T细胞活化的E3泛素连接酶[1]。 |
|---|---|
| 相关类别 | |
| 靶点 |
IC50: < 1 nM (Cbl-b)[1] |
| 体外研究 | Cbl-b-IN-3(化合物23)增强由单独或与抗CD28抗体组合的抗CD3抗体刺激的T细胞的IL-2分泌[1]。 |
| 参考文献 |
| 分子式 | C30H34F3N5O |
|---|---|
| 分子量 | 537.62 |